Mobile App Click here to download our Mobile App for iOS or Android
Not a member? Sign up for free!

Long-Acting Injectable Antipsychotics Reduce Hospitalizations Among Individuals With Early-Phase Schizophrenia

News | January 18, 2021

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Long-acting injectable antipsychotic (LAI) use by individuals with early-phase schizophrenia can significantly delay time to hospitalization. According to a recent study, people with early-phase schizophrenia treated with a monthly LAI for a year or less avoided psychiatric hospitalization for an average of 614 days compared to an average of 531 days until hospitalization for people…

You must be logged in to read the full article: Join PsychU or Log In